Skip to main content
ES
v1.2
Log in
A

Anthem Bioscienc

ANTHEM BIOSCIENCNSE
₹870+0.00 (+0.00%)
Market Cap
₹46,480Cr.
P/E Ratio
78.3
P/B Ratio
16.05
EPS (TTM)
₹11.11
Div Yield
0.23%
ROCE
30.4%
ROE
22.3%
52W Low: ₹57952W High: ₹978
Themes:💊 Pharma & CDMO
Appears in 1 screen
🛡️Low-Volatility Defensives
40
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 26.0% a year over three years.
  • Debt is 0.02× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Anthem_Bioscienc — Price
Interval
||
Style
Failed: 503

Scorecard

Market: risk-off · breadth 37
6/8Minerviniuptrend checks met
69RS Rankvs all stocks, 1–99
bullRSI Regimemomentum range
23Trend (ADX)trend strength
0/4CAN SLIMprice & volume checks
downSupertrendprice vs trailing line
accum.Volume Flowbuying vs selling volume

Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.

Evenstocks Score

Middle third
6.3/ 10Overall
3/ 10Valuation
9/ 10Quality
4/ 10Fundamental
9/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 78.3P/E: 78.3 | P/B: 16.05
Growth
GrowingSales CAGR — 3Y: 26% · 1Y: -2%
Profitability
High MarginROCE: 30.4% | ROE: 22.3%

Key Metrics

Valuation
PEG Ratio 3.73
Price / Sales 23.22x
Price / FCF 73.0x
Book Value ₹54.2
Margins & returns
Operating Margin 40%
Net Margin 28.8%
Return on Assets 16.8%

Frequently Asked Questions

MarketsPortfolioChart